Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

Polygenic contributions to alcohol use and alcohol use disorders across population-based and clinically ascertained samples.

Johnson EC, Sanchez-Roige S, Acion L, Adams MJ, Bucholz KK, Chan G, Chao MJ, Chorlian DB, Dick DM, Edenberg HJ, Foroud T, Hayward C, Heron J, Hesselbrock V, Hickman M, Kendler KS, Kinreich S, Kramer J, Kuo SI, Kuperman S, Lai D, McIntosh AM, Meyers JL, Plawecki MH, Porjesz B, Porteous D, Schuckit MA, Su J, Zang Y, Palmer AA, Agrawal A, Clarke TK, Edwards AC.

Psychol Med. 2020 Jan 20:1-10. doi: 10.1017/S0033291719004045. [Epub ahead of print]

PMID:
31955720
2.

Sex differences in the genetic predictors of Alzheimer's pathology.

Dumitrescu L, Barnes LL, Thambisetty M, Beecham G, Kunkle B, Bush WS, Gifford KA, Chibnik LB, Mukherjee S, De Jager PL, Kukull W, Crane PK, Resnick SM, Keene CD, Montine TJ, Schellenberg GD, Deming Y, Chao MJ, Huentelman M, Martin ER, Hamilton-Nelson K, Shaw LM, Trojanowski JQ, Peskind ER, Cruchaga C, Pericak-Vance MA, Goate AM, Cox NJ, Haines JL, Zetterberg H, Blennow K, Larson EB, Johnson SC, Albert M; Alzheimer’s Disease Genetics Consortium and the Alzheimer’s Disease Neuroimaging Initiative, Bennett DA, Schneider JA, Jefferson AL, Hohman TJ.

Brain. 2019 Sep 1;142(9):2581-2589. doi: 10.1093/brain/awz206.

PMID:
31497858
3.

Genetic Modification of Huntington Disease Acts Early in the Prediagnosis Phase.

Long JD, Lee JM, Aylward EH, Gillis T, Mysore JS, Abu Elneel K, Chao MJ, Paulsen JS, MacDonald ME, Gusella JF.

Am J Hum Genet. 2018 Sep 6;103(3):349-357. doi: 10.1016/j.ajhg.2018.07.017. Epub 2018 Aug 16.

4.

Sex-specific genetic predictors of Alzheimer's disease biomarkers.

Deming Y, Dumitrescu L, Barnes LL, Thambisetty M, Kunkle B, Gifford KA, Bush WS, Chibnik LB, Mukherjee S, De Jager PL, Kukull W, Huentelman M, Crane PK, Resnick SM, Keene CD, Montine TJ, Schellenberg GD, Haines JL, Zetterberg H, Blennow K, Larson EB, Johnson SC, Albert M, Moghekar A, Del Aguila JL, Fernandez MV, Budde J, Hassenstab J, Fagan AM, Riemenschneider M, Petersen RC, Minthon L, Chao MJ, Van Deerlin VM, Lee VM, Shaw LM, Trojanowski JQ, Peskind ER, Li G, Davis LK, Sealock JM, Cox NJ; Alzheimer’s Disease Neuroimaging Initiative (ADNI); Alzheimer Disease Genetics Consortium (ADGC), Goate AM, Bennett DA, Schneider JA, Jefferson AL, Cruchaga C, Hohman TJ.

Acta Neuropathol. 2018 Dec;136(6):857-872. doi: 10.1007/s00401-018-1881-4. Epub 2018 Jul 2.

5.

Population-specific genetic modification of Huntington's disease in Venezuela.

Chao MJ, Kim KH, Shin JW, Lucente D, Wheeler VC, Li H, Roach JC, Hood L, Wexler NS, Jardim LB, Holmans P, Jones L, Orth M, Kwak S, MacDonald ME, Gusella JF, Lee JM.

PLoS Genet. 2018 May 11;14(5):e1007274. doi: 10.1371/journal.pgen.1007274. eCollection 2018 May.

6.

A modifier of Huntington's disease onset at the MLH1 locus.

Lee JM, Chao MJ, Harold D, Abu Elneel K, Gillis T, Holmans P, Jones L, Orth M, Myers RH, Kwak S, Wheeler VC, MacDonald ME, Gusella JF.

Hum Mol Genet. 2017 Oct 1;26(19):3859-3867. doi: 10.1093/hmg/ddx286.

7.

Haplotype-based stratification of Huntington's disease.

Chao MJ, Gillis T, Atwal RS, Mysore JS, Arjomand J, Harold D, Holmans P, Jones L, Orth M, Myers RH, Kwak S, Wheeler VC, MacDonald ME, Gusella JF, Lee JM.

Eur J Hum Genet. 2017 Nov;25(11):1202-1209. doi: 10.1038/ejhg.2017.125. Epub 2017 Aug 23.

8.

Permanent inactivation of Huntington's disease mutation by personalized allele-specific CRISPR/Cas9.

Shin JW, Kim KH, Chao MJ, Atwal RS, Gillis T, MacDonald ME, Gusella JF, Lee JM.

Hum Mol Genet. 2016 Oct 15;25(20):4566-4576. doi: 10.1093/hmg/ddw286.

9.

Sequence-Level Analysis of the Major European Huntington Disease Haplotype.

Lee JM, Kim KH, Shin A, Chao MJ, Abu Elneel K, Gillis T, Mysore JS, Kaye JA, Zahed H, Kratter IH, Daub AC, Finkbeiner S, Li H, Roach JC, Goodman N, Hood L, Myers RH, MacDonald ME, Gusella JF.

Am J Hum Genet. 2015 Sep 3;97(3):435-44. doi: 10.1016/j.ajhg.2015.07.017. Epub 2015 Aug 27.

10.

In situ investigation of the surface morphology evolution of the bulk ceramic Y2Mo3O12 during crystal water release.

Cheng YG, Liu XS, Chen HJ, Chao MJ, Liang EJ.

Phys Chem Chem Phys. 2015 Apr 28;17(16):10363-8. doi: 10.1039/c5cp00045a.

PMID:
25823887
11.

Exome sequencing identifies a novel multiple sclerosis susceptibility variant in the TYK2 gene.

Dyment DA, Cader MZ, Chao MJ, Lincoln MR, Morrison KM, Disanto G, Morahan JM, De Luca GC, Sadovnick AD, Lepage P, Montpetit A, Ebers GC, Ramagopalan SV.

Neurology. 2012 Jul 31;79(5):406-11. doi: 10.1212/WNL.0b013e3182616fc4. Epub 2012 Jun 27.

12.

HLA B*44: protective effects in MS susceptibility and MRI outcome measures.

Chao MJ, Lincoln MR, Dyment DA, Ramagopalan SV, Ebers GC.

Neurology. 2011 Aug 9;77(6):602; author reply 602-3. doi: 10.1212/WNL.0b013e318219a17e. No abstract available.

PMID:
21825276
13.

Vitamin D metabolic pathway genes and risk of multiple sclerosis in Canadians.

Orton SM, Ramagopalan SV, Para AE, Lincoln MR, Handunnetthi L, Chao MJ, Morahan J, Morrison KM, Sadovnick AD, Ebers GC.

J Neurol Sci. 2011 Jun 15;305(1-2):116-20. doi: 10.1016/j.jns.2011.02.032. Epub 2011 Mar 26.

PMID:
21440908
14.

Revisiting the T-cell receptor alpha/delta locus and possible associations with multiple sclerosis.

Watson CT, Para AE, Lincoln MR, Ramagopalan SV, Orton SM, Morrison KM, Handunnetthi L, Handel AE, Chao MJ, Morahan J, Sadovnick AD, Breden F, Ebers GC.

Genes Immun. 2011 Mar;12(2):59-66. doi: 10.1038/gene.2010.65. Epub 2011 Jan 27. Review.

PMID:
21270827
15.

MHC transmission: insights into gender bias in MS susceptibility.

Chao MJ, Ramagopalan SV, Herrera BM, Orton SM, Handunnetthi L, Lincoln MR, Dyment DA, Sadovnick AD, Ebers GC.

Neurology. 2011 Jan 18;76(3):242-6. doi: 10.1212/WNL.0b013e318207b060. Epub 2011 Jan 5.

16.

Parent-of-origin effects at the major histocompatibility complex in multiple sclerosis.

Chao MJ, Herrera BM, Ramagopalan SV, Deluca G, Handunetthi L, Orton SM, Lincoln MR, Sadovnick AD, Ebers GC.

Hum Mol Genet. 2010 Sep 15;19(18):3679-89. doi: 10.1093/hmg/ddq282. Epub 2010 Jul 15.

PMID:
20634196
17.

Epistasis among HLA-DRB1, HLA-DQA1, and HLA-DQB1 loci determines multiple sclerosis susceptibility.

Lincoln MR, Ramagopalan SV, Chao MJ, Herrera BM, Deluca GC, Orton SM, Dyment DA, Sadovnick AD, Ebers GC.

Proc Natl Acad Sci U S A. 2009 May 5;106(18):7542-7. doi: 10.1073/pnas.0812664106. Epub 2009 Apr 20.

18.

Expression of the multiple sclerosis-associated MHC class II Allele HLA-DRB1*1501 is regulated by vitamin D.

Ramagopalan SV, Maugeri NJ, Handunnetthi L, Lincoln MR, Orton SM, Dyment DA, Deluca GC, Herrera BM, Chao MJ, Sadovnick AD, Ebers GC, Knight JC.

PLoS Genet. 2009 Feb;5(2):e1000369. doi: 10.1371/journal.pgen.1000369. Epub 2009 Feb 6.

19.

Epigenetics in multiple sclerosis susceptibility: difference in transgenerational risk localizes to the major histocompatibility complex.

Chao MJ, Ramagopalan SV, Herrera BM, Lincoln MR, Dyment DA, Sadovnick AD, Ebers GC.

Hum Mol Genet. 2009 Jan 15;18(2):261-6. doi: 10.1093/hmg/ddn353.

PMID:
19098025
20.

HLA class I alleles tag HLA-DRB1*1501 haplotypes for differential risk in multiple sclerosis susceptibility.

Chao MJ, Barnardo MC, Lincoln MR, Ramagopalan SV, Herrera BM, Dyment DA, Montpetit A, Sadovnick AD, Knight JC, Ebers GC.

Proc Natl Acad Sci U S A. 2008 Sep 2;105(35):13069-74. doi: 10.1073/pnas.0801042105.

21.

Evidence for genetic regulation of vitamin D status in twins with multiple sclerosis.

Orton SM, Morris AP, Herrera BM, Ramagopalan SV, Lincoln MR, Chao MJ, Vieth R, Sadovnick AD, Ebers GC.

Am J Clin Nutr. 2008 Aug;88(2):441-7.

22.

Methylation of class II transactivator gene promoter IV is not associated with susceptibility to multiple sclerosis.

Ramagopalan SV, Dyment DA, Morrison KM, Herrera BM, Deluca GC, Lincoln MR, Orton SM, Handunnetthi L, Chao MJ, Sadovnick AD, Ebers GC.

BMC Med Genet. 2008 Jul 7;9:63. doi: 10.1186/1471-2350-9-63.

23.

Analysis of 45 candidate genes for disease modifying activity in multiple sclerosis.

Ramagopalan SV, Deluca GC, Morrison KM, Herrera BM, Dyment DA, Lincoln MR, Orton SM, Chao MJ, Degenhardt A, Pugliatti M, Sadovnick AD, Sotgiu S, Ebers GC.

J Neurol. 2008 Aug;255(8):1215-9. doi: 10.1007/s00415-008-0878-7. Epub 2008 Jun 20.

PMID:
18563468
24.

Parent-of-origin effects in MS: observations from avuncular pairs.

Herrera BM, Ramagopalan SV, Lincoln MR, Orton SM, Chao MJ, Sadovnick AD, Ebers GC.

Neurology. 2008 Sep 9;71(11):799-803. doi: 10.1212/01.wnl.0000312377.50395.00. Epub 2008 May 14.

PMID:
18480463
25.

Parental non-inherited HLA resistance alleles do not confer protection against multiple sclerosis.

Ramagopalan SV, Dyment DA, Herrera BM, DeLuca GC, Lincoln MR, Orton SM, Handunnetthi L, Chao MJ, Dessa Sadovnick A, Ebers GC.

J Neuroimmunol. 2008 May 30;196(1-2):170-2. doi: 10.1016/j.jneuroim.2008.03.005. Epub 2008 Apr 22.

PMID:
18433881
26.

Parental transmission of HLA-DRB1*15 in multiple sclerosis.

Ramagopalan SV, Herrera BM, Bell JT, Dyment DA, Deluca GC, Lincoln MR, Orton SM, Chao MJ, Sadovnick AD, Ebers GC.

Hum Genet. 2008 Jan;122(6):661-3. Epub 2007 Oct 31.

PMID:
17972102
27.

The inheritance of resistance alleles in multiple sclerosis.

Ramagopalan SV, Morris AP, Dyment DA, Herrera BM, DeLuca GC, Lincoln MR, Orton SM, Chao MJ, Sadovnick AD, Ebers GC.

PLoS Genet. 2007 Sep;3(9):1607-13. Epub 2007 Jul 20.

28.

Parental transmission of MS in a population-based Canadian cohort.

Herrera BM, Ramagopalan SV, Orton S, Chao MJ, Yee IM, Sadovnick AD, Ebers GC.

Neurology. 2007 Sep 18;69(12):1208-12. Epub 2007 Jun 27.

PMID:
17596583
29.

Transmission of class I/II multi-locus MHC haplotypes and multiple sclerosis susceptibility: accounting for linkage disequilibrium.

Chao MJ, Barnardo MC, Lui GZ, Lincoln MR, Ramagopalan SV, Herrera BM, Dyment DA, Sadovnick AD, Ebers GC.

Hum Mol Genet. 2007 Aug 15;16(16):1951-8. Epub 2007 Jun 20.

PMID:
17584771
30.

Follow-up investigation of 12 proposed linkage regions in multiple sclerosis.

Herrera BM, Cader MZ, Dyment DA, Bell JT, Ramagopalan SV, Lincoln MR, Orton S, Chao MJ, Sadovnick AD, Ebers GC.

Genes Immun. 2006 Jul;7(5):366-71. Epub 2006 Jun 1.

PMID:
16738670
31.

[Stabilising porous silicon luminescence by a novel titanium-doped stain etching approach].

Liang EJ, Du YD, Chao MJ, Wang J.

Guang Pu Xue Yu Guang Pu Fen Xi. 2002 Feb;22(1):12-5. Chinese.

PMID:
12940015

Supplemental Content

Support Center